A universal, amplification-free molecular diagnostic platform that detects plant DNA and RNA directly from leaves and seeds in under 10 minutes. Using antisense oligonucleotide probes and redox-mediated electrochemical readout amplified by gold nanoparticles, the technology enables multiplexed, one-step detection of multiple genetic markers without nucleic acid isolation, validated at 98%+ accuracy in clinical samples.
This solution offers a rapid, amplification-free electrochemical assay for detecting DNA and RNA directly from plant materials such as leaves and seeds. Designed for in-field use, the platform delivers results in under 10 minutes from sample to result, eliminating the need for laboratory-based nucleic acid isolation or polymerase chain reaction (PCR) amplification. The technology is being adapted from a validated human-pathogen diagnostic platform that has demonstrated high accuracy, sensitivity, and specificity across a broad range of targets. For agricultural applications, this means growers, seed companies, plant breeders, and crop protection specialists can obtain genetic confirmation of plant identity, pathogens, or traits on-site, dramatically reducing turnaround time and dependency on centralized laboratories.
Core detection principle:
Validated performance characteristics (from clinical benchmark):
The underlying electrochemical detection platform has been validated across multiple human and pathogen targets, including SARS-CoV-2, H1N1, HIV-1, and others, with clinical sample benchmarking against gold-standard PCR testing. The plant-specific adaptation is at an early development stage, with a planned one-year research effort focused on designing plant-target ASO probes, optimizing the electrode sensing platform, and evaluating assay performance directly on plant samples without nucleic acid isolation. The team is actively seeking industry partnership to guide in-field use cases, provide funding for key personnel, and support commercialization pathways.
Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.